510(k) Report

510(k) · Cleared

Cleared

Invader Factor V

K100980510(k) TraditionalCleared Jun 1, 2011419-day reviewClass II21 CFR 864.7280

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hologic, Inc. · NPQ Test, Factor V Leiden Mutations, Genomic Dna Pcr

Cleared on Jun 1, 2011 as substantially equivalent to DEN030005 (Roche Diagnostics Corp., 2003) after a 419-day review. Its family tree reaches back 1 generation to 2003.

Decided
Jun 1, 2011
Review
419 days
Class
Class II
Product code
NPQ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN030005 (2003). No later device cites it as a predicate yet.

DEN030005 · Factor V Leiden Kit · Roche Diagnostics Corp. · 20032000200220042006200820102012
DEN030005 · Factor V Leiden Kit · Roche Diagnostics Corp. · 20030
  1. Root · 1 generation backDEN030005 Factor V Leiden KitRoche Diagnostics Corp. · 2003
  2. This deviceK100980 Invader Factor VHologic, Inc. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN030005Factor V Leiden KitRoche Diagnostics Corp.2003—
0 (this device)K100980Invader Factor VHologic, Inc.2011—
FIG. 1 — Lineage of K100980, 2003–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NPQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN030005Factor V Leiden Kit
Our reading of the summary gave K033607, which is not in FDA’s 510(k) list. The device the summary names is FDA’s De Novo DEN030005, Factor V Leiden Kit (Roche Diagnostics Corp.), granted Dec 17, 2003; older De Novo requests were first filed under a 510(k) number, so this links to the grant.
Roche Diagnostics Corp.2003—

Also cleared against DEN030005: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 4 other devices also cite its predicate DEN030005.

How does its category compare?

All NPQ devices

NPQ Test, Factor V Leiden Mutations, Genomic Dna Pcr: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · NPQ

1in 2011

2007: 12009: 12010: 22011: 1
2007high 2 (2010) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NPQ

Too few NPQ 510(k)s in any year since 2007 to give a median.

Recalls per year · NPQ

1in 2012

2007: 12008: 22010: 12011: 12012: 1
2007high 2 (2008) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NPQ

2in 2017

2009: 32010: 22011: 152013: 12017: 2
2007high 15 (2011) · low 0 (2007)2025

MAUDE reports naming product code NPQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—10
20080—20
20091—03
20102—12
20111—115
20120—10
20130—01
20140—00
20150—00
20160—00
20170—02
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Invader® Factor V test is an in vitro diagnostic test intended for the detection and genotyping of a single point mutation (G to A at position 1691) of the human Factor V gene in isolated genomic DNA obtained from whole blood potassium EDTA samples from patients with suspected thrombophilia.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K100980: Invader Factor V.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K100980

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026